Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors
Combating Atherosclerosis with Chirality/Phase Dual‐Engineered Nanozyme Featuring Microenvironment‐Programmed Senolytic and Senomorphic Actions
Senolytic Phytocompounds in Redox Signaling
Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial
The prompt to discover senolytics
Adding to the senolytic arsenal
Rejuvenation of diabetic macular edema with senolytic therapy